This chapter is about the giving some general information of Alzheimer’s Disease (AD)
Alzheimer’s Disease (AD) is an age-related progressive neurodegenerative disorder
Alzheimer’s Disease [AD] is one of the most challenging threats to the healthcare system in society.
Elderly persons are at increased risk for developing dementia, and this risk increases with age
Alzheimer’s Disease (AD) is the most common type of dementia that is more commonly seen in advanced age group
Alzheimer’s Disease (AD) is a degenerative brain disorder in which the societal burden of this disease is expected to increase over the next 40 years
Alzheimer’s disease (AD) is a neurodegenarative disease characterized by proggressive
Increasing prevalence and incidence of Alzheimer’s disease pointed the groving importance of protection studies
Department of Medical Biochemistry, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey
Prof. Yildiz Dincer (PhD) is senior scientist in Istanbul University Cerrahpasa Medical Faculty, Department of Medical Biochemistry, Istanbul TR. She received her master degree (1996) and PhD (2000) from the same department. Dr. Dincer has been in Imperial Research Fund-Clare Hall Laboratories, UK as a fellow in 1999, and has gained experience in the field of DNA repair by working in the team of Dr. Tomas Lindahl who shared the 2015 Nobel Prize in Chemistry for work on DNA repair. Dr. Dincer maintains an active research program studying on oxidative DNA damage, DNA repair/apoptosis, antioxidants and epigenetics. Dr. Dincer has published many articles and book chapters. She has served as the editor of various edited collections on topics such as iron deficiency, chemical carcinogens, chemotherapeutics and epigenetics. Dr. Dincer lives with her husband in Istanbul, Turkey.